NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,425 | +409.5% | 150,128 | +1209.8% | 0.02% | +475.0% |
| Q2 2023 | $476 | -100.0% | 11,462 | -65.6% | 0.00% | -85.7% |
| Q2 2022 | $2,315,000 | +62.5% | 33,303 | +75.5% | 0.03% | +86.7% |
| Q4 2021 | $1,425,000 | +33.9% | 18,975 | +107.2% | 0.02% | +7.1% |
| Q3 2021 | $1,064,000 | -2.6% | 9,159 | +86.0% | 0.01% | +16.7% |
| Q2 2021 | $1,092,000 | -78.3% | 4,925 | -83.0% | 0.01% | -75.5% |
| Q4 2020 | $5,028,000 | -21.3% | 29,054 | -49.4% | 0.05% | -61.4% |
| Q3 2020 | $6,388,000 | +52.1% | 57,389 | -19.0% | 0.13% | +16.5% |
| Q2 2020 | $4,200,000 | +225.6% | 70,819 | +269.7% | 0.11% | +53.5% |
| Q1 2020 | $1,290,000 | -59.8% | 19,156 | -49.7% | 0.07% | +18.3% |
| Q4 2019 | $3,207,000 | +384.4% | 38,059 | +329.7% | 0.06% | +160.9% |
| Q3 2019 | $662,000 | – | 8,857 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |